UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 326

Sortiert nach

Design and Synthesis of m1-Selective Muscarinic Agonists: (R)-(−)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI-1017), a Functionally m1-Selective Muscarinic Agonist

Journal of medicinal chemistry, 1998-07, Vol.41 (14), p.2524-2536

1998

Volltextzugriff (PDF)

Identification and characterization of m4 selective muscarinic antagonists

Bioorganic & medicinal chemistry letters, 1998-08, Vol.8 (15), p.1991-1996

1998

Volltextzugriff (PDF)

Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists

Life sciences (1973), 1993, Vol.52 (5), p.505-511

1993

Volltextzugriff (PDF)

Enhancing the diversity of a corporate database using chemical database clustering and analysis

Journal of computer-aided molecular design, 1995-10, Vol.9 (5), p.407-416

1995

Volltextzugriff (PDF)

Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases

Rheumatic diseases clinics of North America, 2018-08, Vol.44 (3), p.475-487

2018

Volltextzugriff (PDF)

Identification and Characterization of m1 Selective Muscarinic Receptor Antagonists

Journal of medicinal chemistry, 1999-02, Vol.42 (3), p.356-363

1999

Volltextzugriff (PDF)

FEATHER DAMAGE DUE TO MYCOTIC INFECTIONS IN WILD TURKEYS

Journal of wildlife diseases, 1989-10, Vol.25 (4), p.534-539

1989

Volltextzugriff (PDF)

Cardiovascular Disease Risk in Patients with Rheumatic Diseases

Clinics in geriatric medicine, 2017-02, Vol.33 (1), p.105-117

2017

Volltextzugriff (PDF)

Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription

Bioorganic & medicinal chemistry, 1997-06, Vol.5 (6), p.1173

1997

Volltextzugriff (PDF)

Systemic Nonarticular Manifestations of Rheumatoid Arthritis: Focus on Inflammatory Mechanisms

Seminars in arthritis and rheumatism, 2009-10, Vol.39 (2), p.132-143

2009

Volltextzugriff (PDF)

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology

Pharmaceutica acta Helvetiae, 2000-03, Vol.74 (2-3), p.141-148

2000

Volltextzugriff (PDF)

The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases

Bioorganic & medicinal chemistry letters, 2006-05, Vol.16 (9), p.2337-2340

2006

Volltextzugriff (PDF)

Transition-state modeling in acyclic stereoselection. A molecular mechanics model for the kinetic formation of lithium enolates

Journal of the American Chemical Society, 1985-04, Vol.107 (8), p.2264-2273

1985

Volltextzugriff (PDF)

Z-(±)-1-azabicyclo[2.2.1]heptan-3-one, O-(3-aryl-2-propynyl) oximes as potential m1-subtype selective muscarinic agonists

Bioorganic & medicinal chemistry letters, 1995-03, Vol.5 (6), p.631-636

1995

Volltextzugriff (PDF)

(±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists

Bioorganic & medicinal chemistry letters, 1995-03, Vol.5 (6), p.637-642

1995

Volltextzugriff (PDF)

A rationale for the design and synthesis of m1 selective muscarinic agonists

Bioorganic & medicinal chemistry letters, 1992-08, Vol.2 (8), p.821-826

1992

Volltextzugriff (PDF)

Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics

Bioorganic & medicinal chemistry letters, 1995-11, Vol.5 (22), p.2755-2760

1995

Volltextzugriff (PDF)

Discovery of selective, small-molecule inhibitors of RNA complexes—1. The tat protein/TAR RNA complexes required for HIV-1 transcription

Bioorganic & medicinal chemistry, 1997-06, Vol.5 (6), p.1173-1184

1997

Volltextzugriff (PDF)

State Statutes Affecting the Social Studies Curriculum

Social studies (Philadelphia, Pa : 1934), 1962-04, Vol.53 (4), p.130-134

Moreland, W. D.

1962

Volltextzugriff (PDF)

Identification and characterization of m1 selective muscarinic receptor antagonists1

Journal of medicinal chemistry, 1999-02, Vol.42 (3), p.356-363

1999

Volltextzugriff (PDF)

NEPTranS - A Shuttle-Tended NEP interplanetary transportation system

Expanding the Frontiers of Space, 2003, Vol.654, p.339-346

2003

Volltextzugriff (PDF)

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology

Pharmacochemistry Library, 2000, Vol.31, p.141-148

2000

Volltextzugriff (PDF)

ChemInform Abstract: Identification and Characterization of m4 Selective Muscarinic Antagonists

ChemInform, 1998-11, Vol.29 (47), p.no-no

1998

Volltextzugriff (PDF)

The Genome of the Ctenophore Mnemiopsis leidyi and Its Implications for Cell Type Evolution

Science (American Association for the Advancement of Science), 2013-12, Vol.342 (6164), p.1336-1336

2013

Volltextzugriff (PDF)

Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin

Antiviral research, 2013-09, Vol.99 (3), p.301-306

2013

Volltextzugriff (PDF)

1 – 25 von 326

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(270)
Mit Volltextzugriff
(277)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(204)
Life Sciences & Biomedicine
(175)
Humans
(147)
Biological And Medical Sciences
(97)
Male
(96)
Female
(89)
Medical Sciences
(81)
Middle Aged
(74)
Rheumatology
(66)
Adult
(56)
Rheumatoid Arthritis
(43)
Aged
(38)
Animals
(38)
Pharmacology. Drug Treatments
(36)
Treatment Outcome
(34)
Pharmacology & Pharmacy
(32)
Double-Blind Method
(31)
Diseases Of The Osteoarticular System
(29)
Arthritis, Rheumatoid - Drug Therapy
(28)
Physical Sciences
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Design and Synthesis of m1-Selective Muscarinic Agonists: (R)-(−)-(Z)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI-1017), a Functionally m1-Selective Muscarinic Agonist

Identification and characterization of m4 selective muscarinic antagonists

Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists

Enhancing the diversity of a corporate database using chemical database clustering and analysis

Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases

Identification and Characterization of m1 Selective Muscarinic Receptor Antagonists

FEATHER DAMAGE DUE TO MYCOTIC INFECTIONS IN WILD TURKEYS

Cardiovascular Disease Risk in Patients with Rheumatic Diseases

Discovery of selective, small-molecule inhibitors of RNA complexes--I. The Tat protein/TAR RNA complexes required for HIV-1 transcription

Systemic Nonarticular Manifestations of Rheumatoid Arthritis: Focus on Inflammatory Mechanisms

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology

The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases

Transition-state modeling in acyclic stereoselection. A molecular mechanics model for the kinetic formation of lithium enolates

Z-(±)-1-azabicyclo[2.2.1]heptan-3-one, O-(3-aryl-2-propynyl) oximes as potential m1-subtype selective muscarinic agonists

(±)-1-Azabicyclo[2.2.1]heptan-3-one, O-(3-methyl-5-aryl-2-penten-4-ynyl) oximes: Potent muscarinic agonists

A rationale for the design and synthesis of m1 selective muscarinic agonists

Inhibition of an HIV-1 Tat-derived peptide binding to TAR RNA by aminoglycoside antibiotics

Discovery of selective, small-molecule inhibitors of RNA complexes—1. The tat protein/TAR RNA complexes required for HIV-1 transcription

State Statutes Affecting the Social Studies Curriculum

Identification and characterization of m1 selective muscarinic receptor antagonists1

NEPTranS - A Shuttle-Tended NEP interplanetary transportation system

CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology

ChemInform Abstract: Identification and Characterization of m4 Selective Muscarinic Antagonists

The Genome of the Ctenophore Mnemiopsis leidyi and Its Implications for Cell Type Evolution

Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin

Suchergebnisse filtern